tiprankstipranks
NeoGenomics (NEO)
NASDAQ:NEO

NeoGenomics (NEO) Cash flow

1,716 Followers

NeoGenomics Cash Flow

NEO's free cash flow for Q4 2023 was $10.73M. For the 2023 fiscal year, NEO's free cash flow was decreased by $54.08M and operating cash flow was $17.78M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -1.95M$ -1.95M$ -65.99M$ 82.54M$ 1.46M$ 23.37M
Investing Cash Flow
$ 76.71M$ 76.71M$ 517.00K$ -741.63M$ -159.44M$ -19.63M
Financing Cash Flow
$ 4.55M$ 4.55M$ 11.83M$ 725.28M$ 235.60M$ 159.47M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.21B$ 342.49M$ 263.18M$ 316.83M$ 250.63M$ 173.02M
Income Tax Paid Supplemental Data
$ 175.00K$ 175.00K$ 180.00K$ 148.00K$ 246.00K$ 319.00K
Interest Paid Supplemental Data
$ 3.38M$ 3.38M$ 3.40M$ 3.06M$ 2.93M$ 4.78M
Issuance Of Capital Stock
$ 4.62M$ 4.62M$ 12.59M$ 15.08M$ 147.60M$ 171.98M
Issuance Of Debt
---$ 334.41M$ 194.47M$ 100.00M
Repayment Of Debt
----$ -103.16M$ -111.45M
Free Cash Flow
$ -30.70M$ -30.70M$ -84.79M$ 18.39M$ -27.64M$ 3.34M
Domestic Sales
------
Foreign Sales
------
Currency in USD

NeoGenomics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis